Exencial Wealth Advisors, LLC Agios Pharmaceuticals, Inc. Transaction History

Exencial Wealth Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$29.58 - $49.78 $1.19 Million - $2.01 Million	-40,322 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $65,435 - $111,709	-2,076 Reduced 4.9%	40,322 $1.43 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $1.28 Million - $2.14 Million	42,398 New	42,398 $2.03 Million

207

60M

365K

457K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.3B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.